The supply of oxygen is now more than three times of what it was during the peak of the first COVID-19 wave, the Prime Minister's Office said on Wednesday, noting that production of all drugs, including Remdesivir, has been ramped up significantly in the last few weeks as India battles the nationwide surge in infections.
At a high-level meeting which Prime Minister Narendra Modi chaired to review the availability and supply of oxygen and medicines, it was noted that states are being provided medicines in good quantities with the Centre in regular touch with the manufacturers to enhance their production and extend all help needed.
The central government is actively monitoring the supply of drugs being used in the management of COVID as well mucormycosis, a rare fungal infection being reported at some places.
Modi said India has a very vibrant pharma sector and the government's continued close coordination with them will ensure proper availability of all medicines.
The PMO said Modi was also briefed about the operations of oxygen rail and sorties by IAF planes besides the status of procurement of oxygen concentrators, oxygen cylinders as well as the status of plants being installed across the country to produce the life-saving gas.
Amid reports of ventilators lying unused in some states with local authorities blaming quality issues in a few cases, Modi said states should be asked to operationalise them in a time-bound manner and resolve technical and training matters with the help of manufacturers.
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU